Explore the urgent need to shift thalassemia care in India from management to prevention through carrier screening and ...
Target Enrollment Achieved with the Inclusion of Participants with Both Dominant and Recessive Forms of BEST DiseaseBaseline ...
A 10-market geographic build-up covering the U.S., Canada, France, Germany, Spain, Italy, the UK, Australia, Japan and South ...
India carries one of the world's largest thalassemia burdens, with nearly 35 to 45 million carriers of the beta thalassemia ...
The winding road of BioCryst Pharmaceuticals’ avoralstat has come to an end. | The company announced it has concluded ...
Derbyshire Times on MSN
'We are on a time limit' Derbyshire mum's desperate plea to save son, 20, with rare kidney disease
A mum has issued an urgent plea for an organ donor to save her son, who has a rare kidney disease.
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.
Sangrail Biologics launches with SNG-101 (f.k.a. ABO-101), a clinical-stage gene therapy for patients with MPS IIIB.
When I arrived in Poland, my goal was clear, to better understand the health and genetic conditions affecting the Karaite ...
InsideHook on MSN
FDA approves first genetic therapy for deafness
Hearing loss is a condition that affect numerous people around the world, but it can take many forms and have many causes. In ...
The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results